Maryland-based TissueGene said today that Invossa, which it touts as the world’s first cell and gene therapy for degenerative arthritis, won approval from the Korea Ministry of Food and Drug Safety.
Invossa is designed to treat osteoarthritis of the knee through a single intra-articular injection.
Get the full story at our sister site, Drug Delivery Business News.
The post First cell and gene therapy for osteoarthritis approved in Korea appeared first on MassDevice.